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The use of tobacco products as dentifrices is still prevalent in various parts of India. Tobacco use in dentifrices is a terrible
scourge which motivates continued use despite its harmful eﬀects. Indian legislation prohibits the use of nicotine in dentifrices.
Nicotine is primarily injurious to people because it is responsible for tobacco addiction and is dependence forming. The present
study was motivated by an interest in examining the presence of nicotine in these dentifrices. Our earlier report indicates the
presence of nicotine in toothpowders. To further curb the menace of tobacco, our team again analysed the toothpowder brands
of previous years and in toothpastes as well. Eight brands of commonly used toothpastes and toothpowders were evaluated by gas
chromatography-mass spectroscopy. On the whole, there are a few successes but much remains to be done. Our ﬁndings indicated
the presence of nicotine in two brands of dant manjans and four brands of toothpastes. Further our ﬁnding underscores the
need for stringent regulations by the regulatory authorities for preventing the addition of nicotine in these dentifrices. Hence
government policy needs to be targeted towards an eﬀective control of tobacco in these dentifrices and should be properly
addressed.
1.Introduction
Nicotine [1-methyl-2-(3-pyridyl-pyrrolidine), C10H14N2]i s
the principal component of tobacco [1]. The predominant
eﬀects of nicotine include rise in blood pressure, heart rate,
respiratory rate; increase in the level of catecholamines in
blood; increase in level of free fatty acids, mobilization of
blood sugar, and it was also found to disturb the antioxidant
defense mechanisms [2–6]. There is strong evidence that
smokeless tobacco use leads to oral mucosal lesions [7, 8]
including oral pre-cancerous lesions, gingival recession [9],
cardiovascularriskfactorsanddisease,diabetes,reproductive
health eﬀects, and overall mortality. Nicotine rapidly crosses
the placenta and has toxic eﬀects on the foetus [10, 11].
Regulartobaccousereduceslifeexpectancybyapproximately
7y e a r s[ 12].
India’s share of the global burden of tobacco-induced
disease and death is substantial [13]. India has one of the
highest rates of oral cancers in the world; 65% of all cancers
in men and 33% of all cancers in women are tobacco related.
Annual incidence of oral cancer is said to be 10 per 1,00,000
per males [14].
In India, there is a widespread misconception that
tobacco is good for the teeth [15]. Tobacco products are
popularasadentifriceindiﬀerentpartsofIndiaandchildren
also use such dentifrices [16]. Among female smokeless
tobacco users, the dominating form is tobacco toothpowder
(41.3%). Among men it was khaini (57.1%) followed by
tobacco toothpowder (8.8%) [16, 17]. Many companies
take advantage of this misconception and exploiting the
addictive nature of nicotine by packaging and positioning
their products as dental care products without explicitly
stating so.
There was an amendment in Drugs & Cosmetics Act,
1940 vide notiﬁcation published in the Gazette of India vide
G.S.R. 443(E) and 444(E) dated 30.04.1992, mentioning that
manufactureandsaleofallcosmeticsandallAyurvedicdrugs
licensed as toothpowders/toothpastes containing tobacco
have been prohibited [6, 18]. However, recent studies2 Journal of Toxicology
reported the presence of nicotine in some toothpowders
[6, 18].
The present studies were motivated by an interest in
examining the presence of nicotine in these dentifrices
to evaluate the presence of nicotine in same brands of
toothpowders (dant manjans)a sr e p o r t e di np r e v i o u ss t u d y .
Furthermore, this year we also ﬁnd it interesting to evaluate
the presence of nicotine in toothpastes as well.
2.MaterialsandMethods
2.1. Chemicals. Eight brands of particular batches of com-
monly used toothpowders (dant manjans) and toothpastes
wereselectedforthestudyfromthelocalmarket.Onesample
from each batch was kept sealed in our laboratory as a refer-
encesample.Thetoothpowdersselectedarecodedasfollows:
Dabur red-M1 (8652), Vicco-M2 (008), Musaka Gul-M3
(not mentioned), Yunadent-M4 (01), Baidyanath-M5 (903),
MDH-M6 (98), Gumtone-M7 (GT509), and Payokil-M8
(1503). The toothpastes selected for study were as follows:
Dabur red-P1 (BD0698), Vicco-P2 (065), Arodent-P3 (64),
Babool-P4 (1498), Herbodent-P5 (20), Colgate Herbal-P6
(B24CP), Ipco-P7 (not mentioned), and Dentobac-P8 (not
mentioned).
Ammonia solution of extra pure quality was purchased
from S.D. Fine-Chem. Ltd., Mumbai, chloroform and
methanol of HPLC grade from Merck Ltd., Mumbai, and
(−)-Nicotine of synthesis grade from Merck-Schuchardt,
Hohebrunn, Germany. Analyses were performed with Gas
chromatography Thermo Electron Corporation with MS
instrument.
2.2. Extraction and Isolation of Nicotine from Toothpowders
and Toothpastes. Extraction and isolation of nicotine from
toothpowders were done as described by Agrawal and
Rajagopal [6]. Extraction and isolation of nicotine from
toothpastes were done by taking 25g of toothpaste in a
conical ﬂask, 15mL NH3 (Strong) was added to completely
humidify the sample followed by 250mL chloroform, and
the conical ﬂask was closed with a cap. This is kept in
mechanicalshakerforaboutonehour.Afterthat,2minhand
shaking and then chloroform extract is then ﬁltered out and
dried [19]. The yield values of alkaloids obtained are 0.154,
0.44, 0.22, 0.12, 0.14, 0.24, 0.56, and 0.37, respectively.
2.3. Method for Identiﬁcation and Quantiﬁcation of Nicotine
by GC-MSD. A l lm a s ss p e c t r aw e r eo b t a i n e dw i t hM S ,
Thermo Electron Corporation. The ion source was operated
in the electron ionization mode (EI; 70eV, 150◦C). Full-
scan mass spectra (m/z 40–450) were recorded for analyte
identiﬁcation.SeparationwasachievedwithaBPfused-silica
capillary column with 5% diphenyl-Poly (dimethylsiloxane
(BP 5), ∼30m length, 0.25mm i.d., 1.0µm ﬁlm thickness.
Samples were injected in the split mode with a split ratio of
1:10. The ﬂow rate of helium as carrier gas was 1.0mL/min.
The GC operating parameters were as follows: injector
temperature, 250◦C; transfer line temperature, 280◦C; oven
temperature, programmed from 100◦C (held for 3min) at
10◦C/min to 280◦C (held for 3min). The ion selected for
quantiﬁcation by SIM was m/z 162.
3. Results
The presence of nicotine in toothpowders (dant manjans)
and toothpastes were conﬁrmed by gas chromatography-
mass spectroscopy (GC-MS) in full scan mode and selective
ion mode (SIM).
3.1. Qualitative Analysis of Toothpowders and Toothpastes.
Out of the eight brands of toothpowders included in the
present study only, two brands were found to contain
nicotine. A comparison of retention time, molecular ion
peak, and base peak shows the presence of nicotine in these
dant manjans (M2 and M3). Retention time of nicotine
was found to be 17.00min. Nicotine presence was identiﬁed
by comparing the RT values of toothpowder extracts with
standard nicotine. The primary target ion of nicotine has a
mass of 162m/z [20]. The molecular ion peak at 162m/z
and base peak at 84m/z corresponds to the fragmentation
of nicotine. The RT of M2 and M3 was found to be 16.99
and 16.94, respectively. This was further conﬁrmed by Mass
spectrum (Figures 1, 2, 3, 4, 5,a n d6).
Similarly,Outoftheeightbrandsoftoothpastesanalysed,
four brands were found to contain nicotine. The RT of P1,
P3,P7,andP8wasfoundtobe17.05,17.16,16.93,and16.91,
respectively as compared to that of nicotine standard 17.00
and was conﬁrmed by its molecular ion peak and base peak
(Figures 7, 8, 9, 10, 11, 12, 13,a n d14).
3.2. Quantitative Analysis of Toothpowders and Toothpastes.
The dant manjan extracts which indicated the presence of
nicotine were also quantiﬁed with GCMS. The nicotine con-
tents determined in GCMS of M1 and M2 were 12.95mg/g
and 216.10mg/g respectively. Similarly, the nicotine content
in toothpaste extracts of P1, P3, P7, and P8 were found to
be 5.752mg/g, 2.093mg/g, 123.82mg/g, and 119.13mg/g,
respectively.
4. Discussion
Abuse of tobacco, like drug and alcohol abuse, is a worldwide
public health problem [21]. India’s tobacco problem is more
complex than probably that of any other country in the
world, with a large consequential burden of tobacco-related
diseaseanddeath[13].Varioustobaccoproductsarepopular
asadentifriceindiﬀerentpartsofIndia[16,22].Tobaccowas
not, perhaps, used for cleansing the teeth, but more so to get
“kick” out of the contents of tobacco, and many companies
exploit the addictive nature of nicotine by packaging and
positioning them as dentifrice [22]. Researches comparing
herbal toothpastes with conventional dentifrices, however,
suggest that there is no speciﬁc advantage of herbal-based
pastes over conventional pastes [23–25].
Indian legislation prohibits the use of tobacco as an
ingredient in dental care products [6, 15]. After the passage
of a law banning the use of tobacco in dental care products,Journal of Toxicology 3
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Figure 1: GC-MS of nicotine in full scan mode.
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Figure 2: GC-MS of nicotine in SIM mode.4 Journal of Toxicology
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Figure 3: GC-MS of toothpowder M2 in full scan mode.
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Figure 4: GC-MS of toothpowder M2 in SIM mode.Journal of Toxicology 5
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Figure 5: GC-MS of toothpowder M3 in full scan mode.
0
20
40
60
80
100
R
e
l
a
t
i
v
e
 
a
b
u
n
d
a
n
c
e
RT: 14.75–18.8    SM: 15 G
3.35E1
TIC F: MS
M3
NL:
15 15.5 16 16.5 17 17.5 18 18.5
Time (min)
15.06 15.18 15.82 16.44
16.95
17.22 17.51 18.22 18.33
(a)
0
20
40
60
80
100
R
e
l
a
t
i
v
e
 
a
b
u
n
d
a
n
c
e
M3 no. 1188  RT: 16.96  AV: 1  NL: 3.10E1
T: + c SIM MS [161.74–162.74]
161.6 161.8 162 162.2 162.4 162.6 162.8
(m/z)
161.98
(b)
Figure 6: GC-MS of toothpowder M3 in SIM mode.6 Journal of Toxicology
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Figure 7: GC-MS of toothpaste P1 in full scan mode.
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Figure 8: GC-MS of toothpaste P1 in SIM mode.Journal of Toxicology 7
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Figure 9: GC-MS of toothpaste P3 in full scan mode.
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Figure 10: GC-MS of toothpaste P3 in SIM mode.8 Journal of Toxicology
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Figure 11: GC-MS of toothpaste P7 in full scan mode.
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Figure 12: GC-MS of toothpaste P7 in SIM mode.Journal of Toxicology 9
16.7 16.8 16.9 17 17.1 17.2
Time (min)
16.6
RT: 16.53–17.28    SM: 11 G 5.08E2
MS P8
0
20
40
60
80
100
R
e
l
a
t
i
v
e
 
a
b
u
n
d
a
n
c
e
NL:
m/z =
161.5–162.5 F: RT: 16.91
Area (%)
N/A
Speciﬁed amount RT
16.91
Sample type
Unknown
Calculated
amount
7147.891 N/A
(a)
50 100 150 200 250 300
(m/z)
0
20
40
60
80
100
R
e
l
a
t
i
v
e
 
a
b
u
n
d
a
n
c
e
65.1
84.1
119.2
133.1
161.1
144.1 209.2 227.1 299.6 185.2 254.2 281.1
P8 no. 1005   RT: 16.91   AV: 1   NL: 5.82E3
T: + c full MS [50–300]
(b)
Figure 13: GC-MS of toothpaste P8 in full scan mode.
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Figure 14: GC-MS of toothpaste P8 in SIM mode.10 Journal of Toxicology
the listing of tobacco as an ingredient was stopped [26].
These products, however, continue to be available openly in
the market, often without mentioning tobacco as one of the
ingredient [6, 16, 17].
Nicotine is a CNS stimulant, which leads to habit forma-
tion subsequently dependence on its users. Nicotine causes
withdrawal symptoms such as anger, anxiety, depressed
mood, diﬃculty in concentration, and craving for tobacco.
Thereisstrongandcompellingevidencethatoraltobaccouse
leads to oral mucosal lesions [7] including oral precancerous
lesions, gingival recession [9], oral cancer [27, 28], and
overall mortality. The risk increases with the duration and
frequency of the habit [29].
The present studies were motivated by an interest in
examining the presence of nicotine in these dentifrices and
to endow with an overview of the tobacco problem in Indian
dentifrices,frompublichealthchallengestopolicyresponses.
With this background, an attempt was made to further curb
the menace of tobacco in commercially available dentifrices
in India and to provide a credible basis for evolving future
tobacco regulation in dentifrices. Our team again analysed
the same brands as of yesteryears with an objective to review
that whether the regulations with respect to tobacco/nicotine
in toothpowders have been adequately implemented or not.
Also it was thought to estimate nicotine in toothpastes of
herbal/ayurvedic origin.
In consistent with the previous report, the presence of
nicotine in four out of eight brands of dant manjans analysed
[6], this year only two bands were found to contain nicotine
and is quantiﬁed as M2 (12.95mg/g) and M3 (216.10mg/g),
respectively. This year out of the eight most commonly
available herbal toothpastes selected for the study, four
brands were found to contain nicotine and was quantiﬁed
as P1 (5.32mg/g), P3 (2.093mg/g), P7 (119.13mg/g), and
P8 (123.82mg/g), respectively. Moreover, these nicotine-
containing toothpowders (dant manjans) and toothpastes
lack pictorial warning which implies that these manufactures
are disguising it as a dentifrice.
A person on a regular oral hygiene uses 2-3g of tooth-
powder/paste each day [30]. The LD50 of nicotine in mice,
rats, and human is 3mg, 50mg, and 40–60mg, respectively.
Thus, the present study indicates that a considerable amount
of nicotine (2–216mg) could enter the oral cavity if these
toothpowders and toothpastes were used. Adults remove
most of the toothpowder/paste from the oral cavity by
rinsing. Children may retain a much greater percentage of
dentifrice than adults, because of incomplete rinsing thus
resulting in ingestion [30]. Once a person is addicted to
nicotine, quitting is very diﬃcult no matter whichever form
he uses it. In a survey, women were found to be addictive
to tobacco paste than males [31]. Thus the presence of
nicotine in these dentifrices even in low concentrations
could considerably lead to addiction and oral mucosal
lesions [7] due to its routine use. Hence this epidemic
of addiction to nicotine among young people may have
enormous implications in public health [32].
Therefore, this study underscores the importance of
support of prevention of tobacco use in developing countries
especially India where population is roaring; tobacco use
threatens to contribute to a growing proportion of the
burden of disease. Thus, even in low concentrations, one
would expect tobacco to be present in these dentifrices to
exert its addictive inﬂuence, which emphasizes the need
for strong economic, legislative, and educational means to
eradicate this menace. However, much more needs to be
done including possibly enacting legislation to stop the
manufacturing of such dentifrices. The ﬁndings of this
study will help to design, implement, and evaluate tobacco
control and prevention programmes. Thus, our study clearly
conﬁrmed the presence of nicotine in few dentifrices, and
regulations have not been implemented properly even after
17 years. Such issues should be eﬀectively addressed by the
regulatory authorities in India and worldwide.
5. Conclusion
With a population of over 1 billion people, tobacco use
contributes to India’s and global public health threat. Our
newﬁndingssubstantiatethepresenceofnicotineinavariety
of dentifrices. Thus even after 17 years of amendment of
Drugs and Cosmetic Act banning tobacco toothpowders
and toothpastes, nicotine is still present in some dentifrices
which clearly shows that the law is not strictly enforced
and implemented. Hence regulatory authorities in India and
internationally should take adequate measures to stop the
addition of nicotine or tobacco to the dentifrices to pro-
vide nicotine-/Tobacco-free dentifrices. However, continued
surveillance of such dental products is necessary in order
to better inform and educate the public regarding the risks
associated with respect to this public health concern.
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